Confirmatory reanalysis of incurred bioanalytical samples

AAPS Journal

Volumn 9, Issue 3, 2007, Pages

  Rocci Jr , Mario L ^a   Devanarayan, Viswanath ^b   Haughey, David B ^a   Jardieu, Paula ^a  

^a ICON PLC   (United Kingdom)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Bioanalytical; ELISA; Immunoassay; Incurred samples; LC MS MS; Reproducibility

Indexed keywords

ACCURACY; ARTICLE; BIOASSAY; DATA ANALYSIS; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD AND DRUG ADMINISTRATION; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MACROMOLECULE; MEDICAL SOCIETY; PATIENT SELECTION; QUALITY CONTROL; REPRODUCIBILITY; SAMPLE SIZE; STANDARD; TANDEM MASS SPECTROMETRY; TOXICITY TESTING; VALIDATION STUDY; WORKSHOP; METHODOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

CHROMATOGRAPHY, LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 38849144763     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/aapsj0903040     Document Type: Article

References (14)

1. Shah DD, Midha KK, Dighe SV, et al. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. J Pharm Sci. 1992;81:309-312.
2. Shah VP. The history of bioanalytical method validation and regulation: evolution of a guidance document on bioanalytical methods validation. AAPS J. 2007;9:E43-E47.
3. Viswanathan CT, Bansal S, Booth B, et al. Workshop/conference report - quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 2007;9:E30-E42.
4. Findlay JWA, Smith WC, Lee JW, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal. 2000;21:1249-1273.
5. FDA/CDER. Guidance for the Industry. Bioanalytical Method Validation. Rockville, MD: US Department of Health and Human Services FDA (CDER) and (CVM); May 2001.
6. DeSilva B, Smith W, Weiner R, et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003;20:1885-1900.
7. Bansal SB. AAPS Bioanalytical Survey. Paper presented at the AAPS 3rd Bioanalytical Workshop: Quantitative Bioanalytical Methods Validation and Implementation - Best Practices for Chromatographic and Ligand Binding Assays; May 1-3, 2006; Washington, DC.
8. Canadian Health Ministry. Guidance for Industry. Conduct and Analysis of Bioavailability and Bioequivalence Studies - Part A: Oral Dosage Formulations Used for Systemic Effects. 1992; Available at: http://hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-id/bio/ bio-a_e.html. Accessed September 27, 2007.
9. Canadian Health Ministry. Guidance for Industry. Conduct and Analysis of Bioavailability and Bioequivalence Studies - Part B: Oral Modified Release Formulations Used for Systemic Effects. 1996; Available at: http://hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/bio/ bio-b_e.html. Accessed September 27, 2007.
10. Canadian Health Ministry. Notice to Industry - Removal of Requirement for 15% Random Replicate Samples. 2003; Available at: http://he-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide--ld/bio/ 15rep_p.html. Accessed September 27, 2007.
11. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;i:307-310.
12. Bland JM, Altman DG. A note on the use of intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med. 1990;20:337-340.
13. Eastwood BJ, Farmen MW, Iversen PW, et al. The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies. J Biomol Screen. 2006;11:253-261.
14. Eli Lilly and Company and the National Institutes of Health (NIH) Chemical Genomics Center (NCGC). Transfer of validated assays, 2005. Available at: http://www.ncgc.nih.gov/guidance/ section2.html#analysis-potency. Accessed September 27, 2007.